Artificial tears combined with Praprofen for the treatment of postoperative dry eye after cataract surgery
人工泪液联合普拉洛芬治疗白内障术后干眼症

摘要

目的 将人工泪液联合普拉洛芬应用在白内障术后干眼症患者中，分析该治疗方法的效果。方法 纳入到本次研究的对象为白内障术后干眼症患者，共计84例，选取时间范围在2022年3月-2023年3月。通过随机数字表法将上述患者分组，即参考组和实验组，每组42例。其中参考组行人工泪液治疗，实验组在上述基础上采取普拉洛芬治疗。评价对比两组治疗效果情况。结果 治疗有效率对比显示，实验组较高（P＜0.05）。角膜荧光素染色评分对比显示，治疗后实验组较低（P＜0.05）。BUT时间对比显示，治疗后实验组较长（P＜0.05）。结论 白内障术后干眼症患者治疗过程中，通过人工泪液联合普拉洛芬治疗，可有助于提升治疗效果，改善患者的相关症状，此种治疗方法值得推广于临床。

Abstract

Objective To apply artificial tears combined with Praprofen in patients with dry eye syndrome after cataract surgery and analyze the effectiveness of this treatment method.
Methods 84 patients with dry eye syndrome after cataract surgery were included in this study, with a selection time range from March 2022 to March 2023. The above patients were divided into a reference group and an experimental group using a random number table method, with 42 cases in each group. The reference group received artificial tear treatment, while the experimental group received Praprofen treatment on the basis of the above. Evaluate and compare the therapeutic effects of two groups.
Results The comparison of treatment effectiveness showed that the experimental group had a higher efficacy rate (P<0.05). The comparison of corneal fluorescein staining scores showed that the experimental group had a lower score after treatment (P<0.05). The comparison of BUT time showed that the experimental group had a longer duration after treatment (P<0.05).
Conclusion   In the treatment process of patients with dry eye syndrome after cataract surgery, the combination of artificial tears and Praprofen can help improve the treatment effect and related symptoms. This treatment method is worth promoting in clinical practice.